281 related articles for article (PubMed ID: 29906669)
21. Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation.
Fishbein I; Kuo YM; Giasson BI; Nussbaum RL
Brain; 2014 Dec; 137(Pt 12):3235-47. PubMed ID: 25351739
[TBL] [Abstract][Full Text] [Related]
22. Alpha-synuclein A53T mutation is not frequent on a sample of Brazilian Parkinson's disease patients.
Longo GS; Pinhel MA; Gregório ML; Oliveira BA; Quinhoneiro DC; Tognola WA; Oliveira FN; Martins DP; Cezario SM; Sado CL; Nakazone MA; Calastri MC; Souza DR
Arq Neuropsiquiatr; 2015 Jun; 73(6):506-9. PubMed ID: 26083886
[TBL] [Abstract][Full Text] [Related]
23. Generation of two iPS cell lines (HIHDNDi001-A and HIHDNDi001-B) from a Parkinson's disease patient carrying the heterozygous p.A30P mutation in SNCA.
Barbuti PA; Santos BFR; Dording CM; Cruciani G; Massart F; Hummel A; Krüger R
Stem Cell Res; 2020 Oct; 48():101951. PubMed ID: 32798915
[TBL] [Abstract][Full Text] [Related]
24. A53T in a parkinsonian family: a clinical update of the SNCA phenotypes.
Tambasco N; Nigro P; Romoli M; Prontera P; Simoni S; Calabresi P
J Neural Transm (Vienna); 2016 Nov; 123(11):1301-1307. PubMed ID: 27250986
[TBL] [Abstract][Full Text] [Related]
25. Metabolic abnormalities and hypoleptinemia in α-synuclein A53T mutant mice.
Rothman SM; Griffioen KJ; Fishbein KW; Spencer RG; Makrogiannis S; Cong WN; Martin B; Mattson MP
Neurobiol Aging; 2014 May; 35(5):1153-61. PubMed ID: 24239384
[TBL] [Abstract][Full Text] [Related]
26. Elevated α-synuclein caused by SNCA gene triplication impairs neuronal differentiation and maturation in Parkinson's patient-derived induced pluripotent stem cells.
Oliveira LM; Falomir-Lockhart LJ; Botelho MG; Lin KH; Wales P; Koch JC; Gerhardt E; Taschenberger H; Outeiro TF; Lingor P; Schüle B; Arndt-Jovin DJ; Jovin TM
Cell Death Dis; 2015 Nov; 6(11):e1994. PubMed ID: 26610207
[TBL] [Abstract][Full Text] [Related]
27. Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study.
Wilson H; Dervenoulas G; Pagano G; Koros C; Yousaf T; Picillo M; Polychronis S; Simitsi A; Giordano B; Chappell Z; Corcoran B; Stamelou M; Gunn RN; Pellecchia MT; Rabiner EA; Barone P; Stefanis L; Politis M
Lancet Neurol; 2019 Aug; 18(8):748-759. PubMed ID: 31229470
[TBL] [Abstract][Full Text] [Related]
28. The heterozygous A53T mutation in the alpha-synuclein gene in a Chinese Han patient with Parkinson disease: case report and literature review.
Xiong WX; Sun YM; Guan RY; Luo SS; Chen C; An Y; Wang J; Wu JJ
J Neurol; 2016 Oct; 263(10):1984-92. PubMed ID: 27393118
[TBL] [Abstract][Full Text] [Related]
29. Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus.
Devine MJ; Ryten M; Vodicka P; Thomson AJ; Burdon T; Houlden H; Cavaleri F; Nagano M; Drummond NJ; Taanman JW; Schapira AH; Gwinn K; Hardy J; Lewis PA; Kunath T
Nat Commun; 2011 Aug; 2():440. PubMed ID: 21863007
[TBL] [Abstract][Full Text] [Related]
30. Isogenic human SNCA gene dosage induced pluripotent stem cells to model Parkinson's disease.
Zafar F; Nallur Srinivasaraghavan V; Yang Chen M; Alejandra Morato Torres C; Schüle B
Stem Cell Res; 2022 Apr; 60():102733. PubMed ID: 35263701
[TBL] [Abstract][Full Text] [Related]
31. Derivation, Characterization, and Neural Differentiation of Integration-Free Induced Pluripotent Stem Cell Lines from Parkinson's Disease Patients Carrying SNCA, LRRK2, PARK2, and GBA Mutations.
Momcilovic O; Sivapatham R; Oron TR; Meyer M; Mooney S; Rao MS; Zeng X
PLoS One; 2016; 11(5):e0154890. PubMed ID: 27191603
[TBL] [Abstract][Full Text] [Related]
32. Genomic DNA levels of mutant alpha-synuclein correlate with non-motor symptoms in an A53T Parkinson's disease mouse model.
Wang W; Song N; Jia F; Tang T; Bao W; Zuo C; Xie J; Jiang H
Neurochem Int; 2018 Mar; 114():71-79. PubMed ID: 29355568
[TBL] [Abstract][Full Text] [Related]
33. Glucocerebrosidase haploinsufficiency in A53T α-synuclein mice impacts disease onset and course.
Tayebi N; Parisiadou L; Berhe B; Gonzalez AN; Serra-Vinardell J; Tamargo RJ; Maniwang E; Sorrentino Z; Fujiwara H; Grey RJ; Hassan S; Blech-Hermoni YN; Chen C; McGlinchey R; Makariou-Pikis C; Brooks M; Ginns EI; Ory DS; Giasson BI; Sidransky E
Mol Genet Metab; 2017 Dec; 122(4):198-208. PubMed ID: 29173981
[TBL] [Abstract][Full Text] [Related]
34. Generation of gene-corrected iPSC line, KIOMi002-A, from Parkinson's disease patient iPSC with LRRK2 G2019S mutation using BAC-based homologous recombination.
Lee SY; Chung SK
Stem Cell Res; 2019 Dec; 41():101649. PubMed ID: 31731184
[TBL] [Abstract][Full Text] [Related]
35. SNCA triplication Parkinson's patient's iPSC-derived DA neurons accumulate α-synuclein and are susceptible to oxidative stress.
Byers B; Cord B; Nguyen HN; Schüle B; Fenno L; Lee PC; Deisseroth K; Langston JW; Pera RR; Palmer TD
PLoS One; 2011; 6(11):e26159. PubMed ID: 22110584
[TBL] [Abstract][Full Text] [Related]
36. Generation of two human induced pluripotent stem cell lines (iPSCs) with mutations of the α-synuclein (SNCA) gene associated with Parkinson's disease; the A53T mutation (LCSBi003) and a triplication of the SNCA gene (LCSBi007).
Novak G; Finkbeiner S; Skibinski G; Skupin A
Stem Cell Res; 2021 Dec; 57():102600. PubMed ID: 34826737
[TBL] [Abstract][Full Text] [Related]
37. Targeted attenuation of elevated histone marks at SNCA alleviates α-synuclein in Parkinson's disease.
Guhathakurta S; Kim J; Adams L; Basu S; Song MK; Adler E; Je G; Fiadeiro MB; Kim YS
EMBO Mol Med; 2021 Feb; 13(2):e12188. PubMed ID: 33428332
[TBL] [Abstract][Full Text] [Related]
38. Multiple system atrophy prions retain strain specificity after serial propagation in two different Tg(SNCA*A53T) mouse lines.
Woerman AL; Oehler A; Kazmi SA; Lee J; Halliday GM; Middleton LT; Gentleman SM; Mordes DA; Spina S; Grinberg LT; Olson SH; Prusiner SB
Acta Neuropathol; 2019 Mar; 137(3):437-454. PubMed ID: 30690664
[TBL] [Abstract][Full Text] [Related]
39. Modeling Parkinson's disease with induced pluripotent stem cells harboring α-synuclein mutations.
Singh Dolt K; Hammachi F; Kunath T
Brain Pathol; 2017 Jul; 27(4):545-551. PubMed ID: 28585381
[TBL] [Abstract][Full Text] [Related]
40. Increased Levels of the Parkinson's Disease-Associated Gene ITPKB Correlate with Higher Expression Levels of α-Synuclein, Independent of Mutation Status.
Di Leva F; Filosi M; Oyston L; Silvestri E; Picard A; Lavdas AA; Lobbestael E; Baekelandt V; Neely GG; Pramstaller PP; Hicks AA; Corti C
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
